Clinical trial
Dynamic Alterations of Th2/Th1 With New Onset of Community-acquired Severe Sepsis
NCT02883218 is registered in ClinicalTrials.gov with Jianfeng Xie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dynamic Alterations of Th2/Th1 With New Onset of Community-acquired Severe Sepsis
- Lead sponsor
- Jianfeng Xie
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2014
- Completion date
- August 1, 2018
- Enrollment
- 85 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.